Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer

P Koppula, Y Zhang, L Zhuang, B Gan - Cancer communications, 2018 - Springer
Cancer cells often upregulate nutrient transporters to fulfill their increased biosynthetic and
bioenergetic needs, and to maintain redox homeostasis. One nutrient transporter frequently …

Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy

P Koppula, L Zhuang, B Gan - Protein & cell, 2021 - academic.oup.com
The cystine/glutamate antiporter SLC7A11 (also commonly known as xCT) functions to
import cystine for glutathione biosynthesis and antioxidant defense and is overexpressed in …

The role of cystine/glutamate antiporter SLC7A11/xCT in the pathophysiology of cancer

N Jyotsana, KT Ta, KE DelGiorno - Frontiers in oncology, 2022 - frontiersin.org
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …

[HTML][HTML] SLC7A11/xCT in cancer: biological functions and therapeutic implications

W Lin, C Wang, G Liu, C Bi, X Wang… - American journal of …, 2020 - ncbi.nlm.nih.gov
Amino acid transporters mediate substrates across cellular membranes and their fine-tuned
regulations are critical to cellular metabolism, growth, and death. As the functional …

[HTML][HTML] NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation

X Liu, Y Zhang, L Zhuang, K Olszewski, B Gan - Genes & diseases, 2021 - Elsevier
Cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11; also known as
xCT) plays a key role in antioxidant defense by mediating cystine uptake, promoting …

The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate

P Koppula, Y Zhang, J Shi, W Li, B Gan - Journal of Biological Chemistry, 2017 - ASBMB
Cancer cells with specific genetic alterations may be highly dependent on certain nutrients
for survival, which can inform therapeutic strategies to target these cancer-specific metabolic …

Amino acid transporters as emerging therapeutic targets in cancer

Y Saito, T Soga - Cancer science, 2021 - Wiley Online Library
Amino acids are indispensable nutrients for both normal and cancer cells. Cancer cells are
unable to synthesize essential amino acids as well as some non‐essential amino acids …

[HTML][HTML] SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells

Y Yan, H Teng, Q Hang, L Kondiparthi, G Lei… - Nature …, 2023 - nature.com
The cystine transporter solute carrier family 7 member 11 (SLC7A11; also called xCT)
protects cancer cells from oxidative stress and is overexpressed in many cancers. Here we …

Slc6a14 and Slc38a5 drive the glutaminolysis and serine–Glycine–One-Carbon pathways in cancer

T Sniegowski, K Korac, YD Bhutia, V Ganapathy - Pharmaceuticals, 2021 - mdpi.com
The glutaminolysis and serine–glycine–one-carbon pathways represent metabolic reactions
that are reprogramed and upregulated in cancer; these pathways are involved in supporting …

The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment

J He, X Wang, K Chen, M Zhang, J Wang - Biochemical pharmacology, 2022 - Elsevier
The solute carrier family 7 member 11 (SLC7A11), an amino acid transporter protein is
frequently overexpressed in human malignancies. The expression and activity of SLC7A11 …